Literature DB >> 3147419

On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.

C Heierli1, M Markert, P H Lambert, T Kuwahara, J P Wauters.   

Abstract

A prospective study was undertaken in 12 haemodialysed patients successively treated on five new as well as re-used dialyser membranes, that is cuprophane, cellulose acetate, polysulphone, polycarbonate, and polyacrylonitrile. A significant reduction of neutrophils occurred with every membrane during their first use, which improved only with cuprophane upon re-use. Thrombocytopenia was noted only when neutropenia reached very low values. Monocyte reduction occurred on cuprophane, cellulose acetate and polycarbonate, but did not improve during second use. C3d accumulation paralleled the time course of neutropenia only with cuprophane and cellulose acetate. Plasma collected at the extreme of neutropenia induced aggregation of control and predialysis cells, but did not aggregate autologous dialysed neutrophils collected at 5 min. Our data indicate that the mechanism linking complement activation to neutropenia is probably triggered by more than one factor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147419

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  The nucleoside diphosphate kinase of human neutrophils.

Authors:  F Guignard; M Markert
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 2.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

3.  Identification and characterization of a novel human neutrophil protein related to the S100 family.

Authors:  F Guignard; J Mauel; M Markert
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

4.  Stimulation of neutrophil functions by C5a(desArg): an in vitro model of haemodialysis.

Authors:  I Eckle; G Kolb; E M Martin; K Havemann
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.